corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 3128

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Budiansky S.
Drug promotion: FDA steps in
Nature 1982 Aug 26; 298:784-785


Abstract:

The Food and Drug Administration has issued a list of recommendations to deal with the problem of preapproval promotion of new drugs. The agency said that it will object to any advertisement that makes claims of safety and efficacy even if the new drug is not specified. On-the-other hand, if the name is specified advertising copy may not suggest the drug’s indications, uses, safety or effectiveness, nor may any other advertisements or even the graphics that appear. Another loophole that concerns the FDA is preapproval promotion of drugs at scientific meetings.

Keywords:
*news story/United States/Food and Drug Administration/FDA/regulation of promotion/new drugs/preapproval promotion/PROMOTIONAL TECHNIQUES: PREAPPROVAL PROMOTION/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION Advertising* Drug Industry* United States United States Food and Drug Administration

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963